๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Safety and Pharmacokinetics of a Single Oral Dose of Gatifloxacin in Patients with Moderate to Severe Hepatic Impairment

โœ Scribed by Dr. Dennis M. Grasela; Ms. Barbara Christofalo; Dr. Georgia D. Kollia; Mr. Glenn Duncan; Dr. Robert Noveck; Dr. James A. Manning Jr.; Dr. Frank P. LaCreta

Book ID
115047983
Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
52 KB
Volume
20
Category
Article
ISSN
0277-0008

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Effect of mild and moderate hepatic impa
Effect of mild and moderate hepatic impairment on azimilide pharmacokinetics following single dose oral administration
โœ Alfred E. Corey; Jeffrey R. Agnew; Eileen C. King; Nikhil J. Parekh; James H. Po ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB

Azimilide dihydrochloride (75-125 mg/day) is currently being developed for use in prolonging the time to recurrence of atrial fibrillation/flutter and for reducing the frequency of shocks in patients with an implantable cardioverting defibrillator. This study investigated the influence of mild and m